IBDEI0N9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11389,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,11390,0)
 ;;=V16.0^^64^697^7
 ;;^UTILITY(U,$J,358.3,11390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11390,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,11390,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,11390,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,11391,0)
 ;;=V16.1^^64^697^8
 ;;^UTILITY(U,$J,358.3,11391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11391,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,11391,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,11391,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,11392,0)
 ;;=V19.6^^64^697^1
 ;;^UTILITY(U,$J,358.3,11392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11392,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,11392,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,11392,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,11393,0)
 ;;=V18.2^^64^697^2
 ;;^UTILITY(U,$J,358.3,11393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11393,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,11393,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,11393,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,11394,0)
 ;;=V17.5^^64^697^4
 ;;^UTILITY(U,$J,358.3,11394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11394,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,11394,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,11394,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,11395,0)
 ;;=V17.7^^64^697^3
 ;;^UTILITY(U,$J,358.3,11395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11395,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,11395,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,11395,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,11396,0)
 ;;=V19.0^^64^697^5
 ;;^UTILITY(U,$J,358.3,11396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11396,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,11396,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,11396,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,11397,0)
 ;;=V16.3^^64^697^6
 ;;^UTILITY(U,$J,358.3,11397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11397,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,11397,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,11397,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,11398,0)
 ;;=V16.41^^64^697^9
 ;;^UTILITY(U,$J,358.3,11398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11398,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,11398,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,11398,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,11399,0)
 ;;=V16.42^^64^697^10
 ;;^UTILITY(U,$J,358.3,11399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11399,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,11399,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,11399,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,11400,0)
 ;;=V16.43^^64^697^11
 ;;^UTILITY(U,$J,358.3,11400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11400,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,11400,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,11400,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,11401,0)
 ;;=V19.5^^64^697^13
 ;;^UTILITY(U,$J,358.3,11401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11401,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,11401,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,11401,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,11402,0)
 ;;=V19.2^^64^697^14
 ;;^UTILITY(U,$J,358.3,11402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11402,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,11402,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,11402,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,11403,0)
 ;;=V17.3^^64^697^16
 ;;^UTILITY(U,$J,358.3,11403,1,0)
 ;;=^358.31IA^5^2
